HK1003980A1 - Dosage form for dispensing drug and human therapy - Google Patents

Dosage form for dispensing drug and human therapy

Info

Publication number
HK1003980A1
HK1003980A1 HK98103203A HK98103203A HK1003980A1 HK 1003980 A1 HK1003980 A1 HK 1003980A1 HK 98103203 A HK98103203 A HK 98103203A HK 98103203 A HK98103203 A HK 98103203A HK 1003980 A1 HK1003980 A1 HK 1003980A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
human therapy
dispensing drug
dispensing
drug
Prior art date
Application number
HK98103203A
Other languages
English (en)
Inventor
Joseph C Deters
Felix Theeuwes
Patrick S-L Wong
David R Swanson
Brian A Barclay
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of HK1003980A1 publication Critical patent/HK1003980A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
HK98103203A 1988-03-21 1998-04-16 Dosage form for dispensing drug and human therapy HK1003980A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/173,524 US4837111A (en) 1988-03-21 1988-03-21 Dosage form for dispensing drug for human therapy

Publications (1)

Publication Number Publication Date
HK1003980A1 true HK1003980A1 (en) 1998-11-13

Family

ID=22632422

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103203A HK1003980A1 (en) 1988-03-21 1998-04-16 Dosage form for dispensing drug and human therapy

Country Status (12)

Country Link
US (1) US4837111A (xx)
EP (1) EP0334465B1 (xx)
JP (1) JP2729072B2 (xx)
AT (1) ATE96308T1 (xx)
CA (1) CA1315687C (xx)
DE (1) DE68910159T2 (xx)
DK (1) DK175637B1 (xx)
ES (1) ES2045400T3 (xx)
HK (1) HK1003980A1 (xx)
IE (1) IE62131B1 (xx)
MX (1) MX9203554A (xx)
PT (1) PT90049B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5002540A (en) * 1989-05-22 1991-03-26 Warren Kirschbaum Intravaginal device and method for delivering a medicament
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
GB9101502D0 (en) * 1991-01-23 1991-03-06 Controlled Therapeutics Sct Controlled release compositions
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
US5226902A (en) * 1991-07-30 1993-07-13 University Of Utah Pulsatile drug delivery device using stimuli sensitive hydrogel
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
US5254349A (en) * 1991-12-06 1993-10-19 Alza Corporation Process for lessening irritation caused by drug
US5266332A (en) * 1991-12-06 1993-11-30 Alza Corporation Method for administering anti-Parkinson drug
US5531734A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Method of altering composition of nutritional product during enteral tube feeding
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
US6080132A (en) * 1998-02-27 2000-06-27 Abbott Laboratories Apparatus for altering characteristics of a fluid
US6309373B1 (en) 1998-08-12 2001-10-30 Abbott Laboratories Apparatus for altering the characteristics of a fluid
US6264695B1 (en) * 1999-09-30 2001-07-24 Replication Medical, Inc. Spinal nucleus implant
US6537584B1 (en) 1999-11-12 2003-03-25 Macromed, Inc. Polymer blends that swell in an acidic environment and deswell in a basic environment
EP1240230B1 (en) * 1999-11-12 2006-03-01 MacroMed, Inc. Swelling and deswelling polymer blends
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
DK1411899T3 (da) * 2001-08-01 2009-06-02 Novartis Ag Smagsmaskerende sammensætning
KR100453288B1 (ko) * 2002-03-12 2004-10-21 한국화학연구원 약물의 제어 방출을 위한 스퀴즈-유형의 삼투성 약물 전달장치
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device
EP1824491A1 (en) * 2004-11-22 2007-08-29 Ranbaxy Laboratories Limited Monocompartment osmotic-controlled delivery system of doxazosin
US20080039473A1 (en) * 2006-08-08 2008-02-14 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
CN101439026B (zh) * 2007-11-23 2011-04-06 北京红林制药有限公司 含有多沙唑嗪或其盐的控释制剂及其制备方法
CN109589491B (zh) * 2019-01-29 2024-01-09 上海安翰医疗技术有限公司 自动给药装置

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4188390A (en) 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4760057A (en) * 1983-06-23 1988-07-26 Merck & Co., Inc. (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
EP0253554A3 (en) * 1986-07-15 1988-07-20 Pfizer Inc. Controlled release drug-containing fibers
US4758569A (en) * 1987-08-26 1988-07-19 Pfizer Inc. Doxazosin as an anti-atherosclerosis agent

Also Published As

Publication number Publication date
CA1315687C (en) 1993-04-06
US4837111A (en) 1989-06-06
EP0334465B1 (en) 1993-10-27
IE890142L (en) 1989-09-21
MX9203554A (es) 1992-09-01
DK135389A (da) 1989-09-22
PT90049B (pt) 1995-03-01
PT90049A (pt) 1989-11-10
JP2729072B2 (ja) 1998-03-18
DE68910159T2 (de) 1994-02-17
EP0334465A1 (en) 1989-09-27
DK135389D0 (da) 1989-03-20
JPH01242528A (ja) 1989-09-27
ATE96308T1 (de) 1993-11-15
DK175637B1 (da) 2005-01-03
ES2045400T3 (es) 1994-01-16
DE68910159D1 (de) 1993-12-02
IE62131B1 (en) 1994-12-14

Similar Documents

Publication Publication Date Title
HK1003980A1 (en) Dosage form for dispensing drug and human therapy
NO306377B1 (no) Doseform for avgivelse av et medikament
GB2184016B (en) Therapeutic device for the administration of medicaments
GR900100659A (en) Dosage form for administering oral hupoglycemic glipizide
GR3026364T3 (en) Pharmaceutical composition for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
NO923859L (no) Medikament
PT88962A (pt) Aparelho aperfeicoado de libertacao transdermica de medicamentos
FR2622798B1 (fr) Forme d'apport dose et dispositif osmotique d'administration d'un medicament pour le traitement de maladies cardio-vasculaires
HU9200051D0 (en) Pharmaceutical freezing mqterial
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
EP0279887A3 (en) Carnitine directed pharmaceutical agents and their use for the manufacture of a medicament for the treatment of muscle disorder
HUT53816A (en) Method for elaborating therapeutical system feeding the agent gradually through the skin
EP0324802A4 (en) Method for the treatment of body tissues and the administration of drugs thereto
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
ZA872128B (en) Chlorpheniramine therapy
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
GR3018365T3 (en) Use of 15-deoxyspergualine as a medicament.
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
IL79521A0 (en) Pharmaceutical dosage unit of tissue plasminogen activator
IL125789A (en) USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES
CS357988A1 (en) Respiratory cannula for distension therapy especially for care of neonatus
NO873805D0 (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.
IT8847847A0 (it) Dispositivo per l'erogazione di ossigeno terapeutico composto e balsamico

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090104